Nemes Rush Group
NVS icon

Nemes Rush Group’s Novartis NVS Stock Holding History

Nemes Rush Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.4K Hold
80
– – ﹤0.01% 548
2026
Q2 		$12.5K Hold
80
– – ﹤0.01% 539
2026
Q1 		$12.2K Hold
80
– – ﹤0.01% 527
2025
Q4 		$11K Buy
+80
New +$10.5K ﹤0.01% 537
2024
Q2 		– Sell
-466
Closed -$45.1K – 655
2024
Q1 		$45.1K Hold
466
– – 0.01% 285
2023
Q4 		$47.1K Hold
466
– – 0.01% 261
2023
Q3 		$47.5K Hold
466
– – 0.01% 257
2023
Q2 		$47K Buy
+466
New +$46.6K 0.01% 271

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
TCTC Holdings
TCTC Holdings Dallas, Texas $4.25B AUM 42% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
AGF Management
AGF Management Toronto, Ontario, Canada $24.5B AUM 50.2% 1-Year Est. Return

Nemes Rush Group's NVS Position: Q3 2026 in Review

Nemes Rush Group held its Novartis (NVS) position steady in Q3 2026 at 80 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

Nemes Rush Group first reported a position in NVS in Q2 2023 and has held it in 8 quarters since. The position peaked at $47.5K in Q3 2023. 943 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Nemes Rush Group held 80 shares of Novartis worth $11.4K as of Q3 2026.
  • Nemes Rush Group left its Novartis share count unchanged in Q3 2026.
  • Novartis made up ﹤0.01% of Nemes Rush Group's portfolio in Q3 2026, its #548 holding.
  • Nemes Rush Group first reported a position in Novartis in Q2 2023 and has held it in 8 quarters since.
  • Nemes Rush Group's Novartis position peaked at $47.5K in Q3 2023.
  • 943 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Nemes Rush Group's 13F filing for Q3 2026, filed 4 Nov 2026.